Figure 3.

ARID1A expression is up‐regulated in basal‐like breast cancer compared to other breast cancer subtypes derived from patient with breast cancer. (A and B) Heatmap for the transcription profiling of ARID1A using microarray (A) and RNA‐sequencing (RNAseq) (B) techniques in different cancer types, including luminal A (LuA), luminal B (LuB), HER2, basal‐like (BL) and normal‐like (NL), derived from patients with breast invasive carcinoma using TCGA database. (C and D) Boxplot for the mRNA levels of ARID1A analysed by microarray (C) and RNA‐sequencing (RNAseq) (D) methods in various types of breast cancer from TCGA database. The statistical differences were analysed by one‐way ANOVA using Turkey's test